BFLY

SEC source: 0001562180-23-002440 · primarydocument.xml · nonDerivative · entry 2

Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,513,491

F2 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33.33% on each anniversary of the grant date, subject to Ms. Getz's continued service through the applicable vesting date.

SEC source: 0001562180-23-002440 · primarydocument.xml · nonDerivative · entry 1

Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 913,491

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 50% on July 1, 2023 with the remainder vesting on January 1, 2024, subject to Ms. Getz's continued service through the applicable vesting date.

SEC source: 0001562180-23-002439 · primarydocument.xml · nonDerivative · entry 2

Weiss Lawrence T · CIK 0001930293 · CLO, GC and Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,316,789

F2 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33.33% on each anniversary of the grant date, subject to Mr. Weiss's continued service through the applicable vesting date.

SEC source: 0001562180-23-002439 · primarydocument.xml · nonDerivative · entry 1

Weiss Lawrence T · CIK 0001930293 · CLO, GC and Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 864,789

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 50% on July 1, 2023 with the remainder vesting on January 1, 2024, subject to Mr. Weiss's continued service through the applicable vesting date.

SEC source: 0001562180-23-001322 · primarydocument.xml · nonDerivative · entry 1

Martin John David · CIK 0001914810 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,516

F1 · shares: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on February 12, 2021.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.33 to $2.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001562180-23-000056 · primarydocument.xml · nonDerivative · entry 1

Stoica Andrei G · CIK 0001808868 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 455,549

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on July 19, 2021.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.40 to $2.4039 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001562180-22-008357 · primarydocument.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · Chief Strategy/Bus Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 629,908

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on December 17, 2020.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.30 to $2.46 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001562180-22-008282 · primarydocument.xml · nonDerivative · entry 1

Quander Troy · CIK 0001883148 · SVP, Regulatory and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,993

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on September 16, 2021.

SEC source: 0001562180-22-006993 · primarydocument.xml · nonDerivative · entry 1

Stoica Andrei G · CIK 0001808868 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457,022

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on July 19, 2021.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $4.63 to $4.79 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001562180-22-006725 · primarydocument.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · Chief Strategy/Bus Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 656,793

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on December 17, 2020.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $5.44 to $5.61 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001562180-22-006683 · primarydocument.xml · nonDerivative · entry 1

Quander Troy · CIK 0001883148 · SVP, Regulatory and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,367

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on September 16, 2021.

SEC source: 0001562180-22-005334 · primarydocument.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · Chief Strategy/Bus Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676,932

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on December 17, 2020.

SEC source: 0001104659-22-073489 · tm2219003-1_4seq1.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,576,135

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073505 · tm2219003-8_4seq1.xml · nonDerivative · entry 1

Schwartz Erica · CIK 0001872122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,135

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073492 · tm2219003-3_4seq1.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,388

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073490 · tm2219003-2_4seq1.xml · nonDerivative · entry 1

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,388

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073502 · tm2219003-7_4seq1.xml · nonDerivative · entry 1

HAMMERGREN JOHN H · CIK 0001197887 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,388

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073496 · tm2219003-5_4seq1.xml · nonDerivative · entry 1

Edelman Elazer R · CIK 0001662771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,329

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073499 · tm2219003-6_4seq1.xml · nonDerivative · entry 1

Carfora Dawn · CIK 0001842799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,397

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-073494 · tm2219003-4_4seq1.xml · nonDerivative · entry 1

Pettiti Gianluca · CIK 0001844600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,402

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs were issued to the Reporting Person as the annual grant to nonemployee directors pursuant to the Issuer's Amended and Restated Nonemployee Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors. The RSUs vest in full on the date of the Issuer's 2023 Annual Stockholders Meeting, subject to the Reporting Person's continued service on the Board of Directors on such date.

SEC source: 0001104659-22-067131 · tm2217425-2_4seq1.xml · nonDerivative · entry 1

Dillon Tamara · CIK 0001929933 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327,868

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest as to 25% on May 31, 2023, with the remainder vesting in equal quarterly installments over the following three years, subject to Ms. Dillon's continued service through the applicable vesting date.

SEC source: 0001104659-22-064245 · tm2216668-2_4seq1.xml · nonDerivative · entry 1

Weiss Lawrence T · CIK 0001930293 · CLO, GC and Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690,789

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest as to 25% on May 23, 2023, with the remainder vesting in three equal annual installments thereafter, subject to Mr. Weiss's continued service through the applicable vesting date.

SEC source: 0001104659-22-055840 · tm2214349-2_4seq1.xml · derivative · entry 2

Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,915

Underlying: Class A Common Stock · 314,915 shares

Expires 2032-05-02

F2 · derivative.exercise_date: The shares underlying this option vest as to 25% on May 2, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Getz's continued service through the applicable vesting date.

SEC source: 0001104659-22-055840 · tm2214349-2_4seq1.xml · nonDerivative · entry 1

Getz Heather C · CIK 0001481485 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 628,491

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% on May 2, 2023, with the remainder vesting in three equal annual installments thereafter, subject to Ms. Getz's continued service through the applicable vesting date.

SEC source: 0001562180-22-002940 · primarydocument.xml · nonDerivative · entry 1

Martin John David · CIK 0001914810 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,357

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Martin's continued service through the applicable vesting date.

SEC source: 0001562180-22-002939 · primarydocument.xml · nonDerivative · entry 1

Quander Troy · CIK 0001883148 · SVP, Regulatory and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,860

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Mr. Quander's continued service through the applicable vesting date.

SEC source: 0001562180-22-002941 · primarydocument.xml · nonDerivative · entry 1

Pugh Stacey · CIK 0001851969 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 570,945

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Pugh's continued service through the applicable vesting date.

SEC source: 0001562180-22-002942 · primarydocument.xml · nonDerivative · entry 1

Stoica Andrei G · CIK 0001808868 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,798

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Stoica's continued service through the applicable vesting date.

SEC source: 0001562180-22-002944 · primarydocument.xml · derivative · entry 2

Fruchterman Todd · CIK 0001481217 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,743

Underlying: Class A Common Stock · 88,743 shares

Expires 2032-03-22

F2 · derivative.exercise_date: The shares underlying this option vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Fruchterman's continued service through the applicable vesting date.

SEC source: 0001562180-22-002944 · primarydocument.xml · nonDerivative · entry 1

Fruchterman Todd · CIK 0001481217 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,531,208

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33%on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Fruchterman's continued service through the applicable vesting date.

SEC source: 0001562180-22-002943 · primarydocument.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · General Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 383,512

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date.

SEC source: 0001562180-22-002938 · primarydocument.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · Chief Strategy/Bus Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693,001

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Mr. Shahida's continued service through the applicable vesting date.

SEC source: 0001104659-22-037171 · tm2210281-1_4seq1.xml · nonDerivative · entry 4

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

4C Holdings I, LLC · CIK 0001846591 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By 4C Holdings V, LLC

Disclosed balance after: 8,845,238

F1 · kind: In connection with estate planning, transfers of 6,202,545 shares of Class A Common Stock transferred by 23rd Century Capital LLC to 2012 JMR Trust Common, LLC and 6,202,545 shares of Class B Common Stock transferred by 4C Holdings I, LLC to 4C Holdings V, LLC, in each case with no consideration received in exchange therefor other than the shares to be received by the transferees.

F2 · ownership.nature: Dr. Rothberg is a member of 23rd Century Capital LLC and the Manager of 1997 JMR Trust Common, LLC, 2012 JMR Trust Common, LLC, 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC, and is the spouse of Bonnie E Gould Rothberg MD. Dr. Rothberg disclaims beneficial ownership of the securities held by these persons and entities except to the extent of his pecuniary interest therein.

SEC source: 0001104659-22-037171 · tm2210281-1_4seq1.xml · nonDerivative · entry 3

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

4C Holdings I, LLC · CIK 0001846591 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By 4C Holdings I, LLC

Disclosed balance after: 9,716,596

F1 · kind: In connection with estate planning, transfers of 6,202,545 shares of Class A Common Stock transferred by 23rd Century Capital LLC to 2012 JMR Trust Common, LLC and 6,202,545 shares of Class B Common Stock transferred by 4C Holdings I, LLC to 4C Holdings V, LLC, in each case with no consideration received in exchange therefor other than the shares to be received by the transferees.

F2 · ownership.nature: Dr. Rothberg is a member of 23rd Century Capital LLC and the Manager of 1997 JMR Trust Common, LLC, 2012 JMR Trust Common, LLC, 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC, and is the spouse of Bonnie E Gould Rothberg MD. Dr. Rothberg disclaims beneficial ownership of the securities held by these persons and entities except to the extent of his pecuniary interest therein.

SEC source: 0001104659-22-037171 · tm2210281-1_4seq1.xml · nonDerivative · entry 2

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

4C Holdings I, LLC · CIK 0001846591 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2012 JMR Trust Common, LLC

Disclosed balance after: 6,202,545

F1 · kind: In connection with estate planning, transfers of 6,202,545 shares of Class A Common Stock transferred by 23rd Century Capital LLC to 2012 JMR Trust Common, LLC and 6,202,545 shares of Class B Common Stock transferred by 4C Holdings I, LLC to 4C Holdings V, LLC, in each case with no consideration received in exchange therefor other than the shares to be received by the transferees.

F2 · ownership.nature: Dr. Rothberg is a member of 23rd Century Capital LLC and the Manager of 1997 JMR Trust Common, LLC, 2012 JMR Trust Common, LLC, 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC, and is the spouse of Bonnie E Gould Rothberg MD. Dr. Rothberg disclaims beneficial ownership of the securities held by these persons and entities except to the extent of his pecuniary interest therein.

SEC source: 0001104659-22-037171 · tm2210281-1_4seq1.xml · nonDerivative · entry 1

ROTHBERG JONATHAN M · CIK 0001076352 · Director · 10% owner

4C Holdings I, LLC · CIK 0001846591 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By 23rd Century Capital LLC

Disclosed balance after: 0

F1 · kind: In connection with estate planning, transfers of 6,202,545 shares of Class A Common Stock transferred by 23rd Century Capital LLC to 2012 JMR Trust Common, LLC and 6,202,545 shares of Class B Common Stock transferred by 4C Holdings I, LLC to 4C Holdings V, LLC, in each case with no consideration received in exchange therefor other than the shares to be received by the transferees.

F2 · ownership.nature: Dr. Rothberg is a member of 23rd Century Capital LLC and the Manager of 1997 JMR Trust Common, LLC, 2012 JMR Trust Common, LLC, 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC, and is the spouse of Bonnie E Gould Rothberg MD. Dr. Rothberg disclaims beneficial ownership of the securities held by these persons and entities except to the extent of his pecuniary interest therein.

SEC source: 0001562180-22-002857 · primarydocument.xml · nonDerivative · entry 1

Fielding Stephanie · CIK 0001841070 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,079

F1 · kind: Shares withheld by the Registrant to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on December 17, 2020.

SEC source: 0001562180-22-002856 · primarydocument.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · Chief Strategy/Bus Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 635,721

F1 · kind: Shares withheld by the Registrant to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on December 17, 2020.

SEC source: 0001567619-22-006997 · doc1.xml · nonDerivative · entry 1

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 5,464,751

F1 · shares: These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P.

F2 · price: This price reflects the weighted average price for open-market purchases of Shares on March 15, 2022 within a $1.00 range. The actual prices for these transactions range from $4.405 to $4.65, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.

F3 · ownership.nature: Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares.

F5 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

SEC source: 0001140361-22-009169 · form4.xml · derivative · entry 4

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,745,933

Underlying: Class A Common Stock · 2,107,400 shares

Expires not disclosed

F6 · kind: Longview distributed in kind these Warrants (as defined in footnote 7) to certain of its members on a pro rata basis based on their ownership interest in Longview, for no consideration.

F7 · derivative.exercise_date: Each warrant entitles the holder, upon exercise, to purchase one Share at a price of $11.50 per Share (the "Warrants"). These Warrants became exercisable beginning May 26, 2021 and expire on February 12, 2026.

F7 · derivative.expiration_date: Each warrant entitles the holder, upon exercise, to purchase one Share at a price of $11.50 per Share (the "Warrants"). These Warrants became exercisable beginning May 26, 2021 and expire on February 12, 2026.

F2 · ownership.nature: Longview, or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities.

F4 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

SEC source: 0001140361-22-009169 · form4.xml · nonDerivative · entry 1

ROBBINS LARRY · CIK 0001228603 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 7,115,437

F1 · kind: Longview Investors LLC ("Longview") distributed in kind these shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") to certain of its members on a pro rata basis based on their ownership interest in Longview, for no consideration.

F2 · ownership.nature: Longview, or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities.

F4 · ownership.nature: Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.

SEC source: 0001104659-22-031600 · tm228660d7_4.xml · nonDerivative · entry 1

Martin John David · CIK 0001914810 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,568

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Martin's continued service through the applicable vesting date.

SEC source: 0001104659-22-031591 · tm228660-1_4seq1.xml · nonDerivative · entry 1

Quander Troy · CIK 0001883148 · SVP, Regulatory and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,994

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Mr. Quander's continued service through the applicable vesting date.

SEC source: 0001104659-22-031599 · tm228660d6_4.xml · nonDerivative · entry 1

Pugh Stacey · CIK 0001851969 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496,232

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Pugh's continued service through the applicable vesting date.

SEC source: 0001104659-22-031594 · tm228660-3_4seq1.xml · nonDerivative · entry 1

Stoica Andrei G · CIK 0001808868 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,142

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Stoica's continued service through the applicable vesting date.

SEC source: 0001104659-22-031598 · tm228660d5_4.xml · derivative · entry 2

Fruchterman Todd · CIK 0001481217 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,620

Underlying: Class A Common Stock · 258,620 shares

Expires 2032-03-04

F2 · derivative.exercise_date: The shares underlying this option vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Fruchterman's continued service through the applicable vesting date.

SEC source: 0001104659-22-031598 · tm228660d5_4.xml · nonDerivative · entry 1

Fruchterman Todd · CIK 0001481217 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419,139

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Dr. Fruchterman's continued service through the applicable vesting date.

SEC source: 0001104659-22-031597 · tm228660d4_4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · General Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,723

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date.

SEC source: 0001104659-22-031592 · tm228660-2_4seq1.xml · nonDerivative · entry 1

Shahida Darius · CIK 0001840972 · CSO & CBDO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 652,151

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Mr. Shahida's continued service through the applicable vesting date.

SEC source: 0001562180-22-001585 · primarydocument.xml · nonDerivative · entry 1

Pugh Stacey · CIK 0001851969 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,612

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on February 11, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $5.75 to $6.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.